Analgesics in the Netherlands

Analgesics in the Netherlands

  • November 2017 •
  • 18 pages •
  • Report ID: 149697
Analgesics is expected to record a relatively strong increase in sales over the forecast period, with growth rates set to be well in excess of what was recorded over the review period. Greater consumer confidence in OTC analgesics due to tighter regulatory restrictions and the increasing trend of self-medication for minor ailments are expected to result in a value CAGR of 3% at constant 2017 prices. Nevertheless, sales are likely to be suppressed somewhat by the cautious attitudes that many Dutc...

Euromonitor International’s Analgesics in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage:
Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=Netherlands Industry=OTC ParentIndustry=LifeSciences Date=201711 Topic=Demand Publisher=EuromonitorInternational Price=1000